Skip to main content
. Author manuscript; available in PMC: 2022 Feb 1.
Published in final edited form as: Depress Anxiety. 2020 Aug 12;38(2):124–133. doi: 10.1002/da.23088

Figure 3.

Figure 3.

Post-treatment HAMD (Panel A-Top) and BDI (Panel B-Bottom) scores by treatment group and pre-treatment levels of state anxiety, adjusted for pre-intervention anxiety, pre-intervention depression, age, gender, and race. Values represent predicted scores for a typical participant at the 25th and 75th percentile (scores of 43 and 55, respectively) of baseline state anxiety. Participants with low state anxiety in the active treatments had lower HAMD depression scores compared to those with high anxiety. The pattern was similar for BDI-II scores, but this difference was less pronounced in the sertraline condition, with both high and low anxiety showing low post-treatment scores. Error bars represent 95% confidence limits.